Technology News and Research

RSS

Researchers develop hinged figure skate prevent to joint injuries

Researchers at the University of Delaware have redesigned the traditional figure skate, with the goal of reducing the joint injuries that plague many competitive skaters.

29 Apr 2004

Time bomb in heart leads to heart failure in some congenital heart disease patients

However, surgical correction of certain forms of congenital heart disease may not fix the underlying molecular trigger that drives progressive heart failure and sudden death later in life, according to new research from the University of California, San Diego (UCSD) School of Medicine.

29 Apr 2004

Space technology may help fertility of a woman with cancer

Using technology borrowed from the National Aeronautics and Space Administration (NASA), scientists at the University of Pittsburgh's McGowan Institute for Regenerative Medicine have taken the first steps toward successfully preserving ovarian tissue from rats and mice in culture, including immature egg follicles, according to a study in the current issue of the journal Tissue Engineering.

29 Apr 2004

Scientists looking for 480 people to test experimental anthrax vaccine

Scientists in Rochester and 11 other cities around the nation are beginning tests of an experimental vaccine aimed at protecting people against anthrax, a rare disease that, like smallpox, has become more threatening with the emergence of bioterrorism.

28 Apr 2004

Bypass surgery results in better five-year survival than balloon angioplasty and stent procedures

Bypass surgery results in better five-year survival than balloon angioplasty and stent procedures for patients with serious coronary artery disease and additional health conditions such as diabetes

28 Apr 2004

Results look promising in Alzheimer’s gene therapy trial

Surgical placement of genetically modified tissue directly into the brains of patients with Alzheimer’s disease, an experimental approach to delaying brain cell loss associated with the disease, leads to increased metabolic activity in the brain, with cells apparently responding to the insertion of growth factor-producing grafts

28 Apr 2004

Robot teaches 50-year-old man paralyzed to walk again

A 50-year-old man paralyzed from the neck down in a devastating motorcycle accident ayear ago is learning to walk again with the help of a robot named Lokomat at UT Southwestern Medical Center at Dallas.

28 Apr 2004

Prana Biotechnology gets US$20 million funding for Alzheimer’s treatment research

Prana Biotechnology Limited has announced that it entered into definitive agreements with new institutional investors for the purchase of US$20 million of securities through the sale of 4 million ADR's at US$5.00 per ADR.

28 Apr 2004

$4.5 million contract to develop heart assist devices for infants

The University of Pittsburgh's McGowan Institute for Regenerative Medicine has been awarded a five-year $4.5 million contract from the National Heart, Lung, and Blood Institute to develop a heart assist device for infants.

28 Apr 2004

AGT Biosciences Limited and ChemGenex Therapeutics today announced merger agreement

AGT Biosciences Limited of Melbourne, Australia and privately held ChemGenex Therapeutics, Inc. of Menlo Park, California, today announced that they have signed a merger agreement. The cross-border merger creates a new, genomics-driven pharmaceutical company with leading edge capabilities for drug discovery and development, as well as two drug candidates in Phase II human trials for cancer.

28 Apr 2004

BioTime awarded a research grant for blood plasma volume expander

BioTime, Inc. has announced that it has been awarded a research grant by the National Heart, Lung, and Blood Institute division of the National Institutes of Health (NIH) for use in the development of its HetaCool® blood plasma volume expander following peer review.

27 Apr 2004

Helix BioMedix announces positive results of comparative product anti-wrinkle study

Helix BioMedix today announced that it has completed a 12-week consumer product test comparing the company's anti-wrinkle peptide, HB168 with Renova(R), a currently marketed FDA approved product.

27 Apr 2004

Biological bandages are being successfully used to treat patients with severe burns

Doctors have been impressed with the rapid recovery rates instigated by the ‘tailor-made ’ discs, which have been devised by a research team at the Sheffield company, CellTran, with financial support from the Wellcome Trust biomedical research charity and the White Rose Technology Seedcorn Fund. They will be officially launched at the British Burn Association’s annual meeting in Manchester tomorrow (28th).

27 Apr 2004

UK moves towards controversial 'biometric' passports

In a move which is surely to cause controversy Home Secretary David Blunkett has published a draft Bill on a national ID card scheme.

26 Apr 2004

Medical students are seeking to uncover a silent killer, glaucoma

Like private eyes, a group of medical students at the College of Medicine are seeking to uncover a silent killer attacking unsuspecting citizens of Tucson: glaucoma.

26 Apr 2004

New ion exchange resin will help people with thyroid gland problems

Rohm and Haas Company has introduced Amberlite® PWA2 ion exchange resin, the first resin specifically designed for the selective removal of perchlorate from drinking water.

26 Apr 2004

FDA fast tracks human African sleeping sickness (Trypanosomiasis) drug

Immtech International, Inc. has announced that the U.S. Food and Drug Administration has granted Immtech's first oral drug, DB289, fast track drug development designation for use to treat human African sleeping sickness (Trypanosomiasis).

26 Apr 2004

Clinical trial of enzyme replacement therapy for the treatment of Gaucher disease

Transkaryotic Therapies, Inc. today announced that it has initiated a clinical trial to evaluate the safety and clinical activity of GA-GCB, its enzyme replacement therapy for the treatment of Gaucher disease.

26 Apr 2004

SARS antibody sent to China

Responding to a request from a Chinese biotechnology company working closely with officials in China, Medarex, Inc. and the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) have shipped to Beijing a sample of the fully human antibody to SARS developed by Medarex and MBL/UMMS.

26 Apr 2004

New analytical approach that combines genetic and clinical data to give individualized prognosis of cancer recurrence

Researchers at Duke University have developed a new analytical approach that combines genetic and clinical data to give cancer patients an individualized prognosis of their cancer recurrence. The information could prove critical in deciding how aggressively to treat the disease following surgery.

26 Apr 2004

Technology News and Research

Researchers develop hinged figure skate prevent to joint injuries

Time bomb in heart leads to heart failure in some congenital heart disease patients

Space technology may help fertility of a woman with cancer

Scientists looking for 480 people to test experimental anthrax vaccine

Bypass surgery results in better five-year survival than balloon angioplasty and stent procedures

Results look promising in Alzheimer’s gene therapy trial

Robot teaches 50-year-old man paralyzed to walk again

Prana Biotechnology gets US$20 million funding for Alzheimer’s treatment research

$4.5 million contract to develop heart assist devices for infants

AGT Biosciences Limited and ChemGenex Therapeutics today announced merger agreement

BioTime awarded a research grant for blood plasma volume expander

Helix BioMedix announces positive results of comparative product anti-wrinkle study

Biological bandages are being successfully used to treat patients with severe burns

UK moves towards controversial 'biometric' passports

Medical students are seeking to uncover a silent killer, glaucoma

New ion exchange resin will help people with thyroid gland problems

FDA fast tracks human African sleeping sickness (Trypanosomiasis) drug

Clinical trial of enzyme replacement therapy for the treatment of Gaucher disease

SARS antibody sent to China

New analytical approach that combines genetic and clinical data to give individualized prognosis of cancer recurrence

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News